CGEN COMPUGEN LTD

CGEN financial statements, revenue, balance sheet, cash flow, and SEC filings

CIK: 1119774 Exchange: Nasdaq SIC: 2836 (Biological Products, (No Diagnostic Substances))
Showing 3 of 17 annual and 0 of 0 quarterly periods. Full history available with a free account or via API.

▼ Company Profile

Filer Category
Accelerated filer
Entity Type
Other
Industry (SIC)
2836 Biological Products, (No Diagnostic Substances)
Incorporated
L3
Fiscal Year End
December (1231)
Phone
011-972-3-765-8585
EIN
000000000
Headquarters
HOLON, L3, 5885849

▼ Key Metrics (FY 2025)

As of Dec 31, 2025
Financials
Revenue
$72.76M
Net Income
$35.34M
Total Assets
$156.57M
Total Equity
$102.73M
Total Debt
-
Free Cash Flow
$31.33M
Ratios
Gross Margin
87.3%
Operating Margin
43.1%
Net Margin
48.6%
Return on Equity
34.4%
Return on Assets
22.6%
Current Ratio
6.56x
FCF / Assets
20%
Revenue Growth (YoY)
161.1%
EPS Growth (YoY)
337.5%

▼ FY 2025 Summary Analysis

Annual report ending Dec 31, 2025

Overview and Growth

COMPUGEN LTD generated $72.76M of revenue in fiscal 2025, with net income of $35.34M and an operating cash inflow of $31.63M. Revenue of $72.76M sets the scale for evaluating how effectively sales translated into profit and cash during the year. Compared with $27.86M in fiscal 2024, revenue recorded a 161.1% year-over-year increase. The company reported diluted EPS of $0.38, adding a shareholder-level measure to the absolute income figures considered below. The revenue-to-assets relationship was 0.46x, showing the sales generated relative to the resources carried on the balance sheet.

Profitability

The first profit layer was $63.51M of gross profit, the amount available after reported direct revenue costs to absorb operating expenses. Gross margin was 87.3%, so that share of each revenue unit remained after the cost of revenue reported for the period. The reported operating result was $31.33M, capturing profitability after direct costs and the operating expenses reflected in the statements. Relative to revenue, operating income represented 43.1%, showing how efficiently sales converted into operating profit. Net income came to $35.34M, completing the progression from revenue through gross and operating profitability to the final reported result. The final earnings result represented 48.6% of revenue, connecting the absolute net income figure with the company’s top-line scale. The earnings statement records $35.40M of pretax income, the profit base against which the reported tax provision can be assessed. Pretax income represented 48.6% of revenue, placing earnings before tax in the context of the company’s operating scale. Income tax expense totaled $54.00K, providing the reported tax component that separates pretax and after-tax earnings. The effective relationship between income tax and positive pretax income was 0.2%, without assuming a statutory-rate comparison. Return on period-end equity was 34.4%, relating annual net income to the equity capital on the balance sheet. Return on period-end assets was 22.6%, connecting net income with the company’s total asset base.

Liquidity and Capital Structure

At period end, the $156.57M asset base was financed through $53.84M of liabilities and $102.73M of equity. The near-term balance sheet paired $148.02M of current assets with $22.57M of current liabilities at the reporting date. Current assets covered current liabilities by 6.56x, leaving a positive buffer for near-term obligations. Cash and equivalents totaled $90.60M, identifying the most liquid reported component available within the broader current-asset balance. Measured only with cash and equivalents, coverage of current liabilities was 401.4%, excluding receivables and other current assets. The liabilities-to-assets relationship was 34.4%, placing reported obligations against the full positive asset balance. Measured against total assets, cash and equivalents represented 57.9%, a balance-sheet composition measure rather than a liquidity forecast. Compared with $115.00M in fiscal 2024, the current asset base moved 36.2% and finished higher. Reported equity changed 87.1% from $54.91M in fiscal 2024, placing the current capital base higher year over year.

Cash Flow and Earnings Quality

Operating activities produced a cash inflow of $31.63M, giving the cash-flow counterpart to the accrual-based profit measures reported for the year. Operating cash flow equaled 0.9x of net income, showing how strongly accounting earnings converted into cash from operations. The cash-flow statement records $306.00K of capital expenditures, the investment amount considered after operating cash generation. Capital spending absorbed 1.0% of operating cash flow, quantifying the share of cash from operations directed to investment. After capital spending, free cash flow was $31.33M, leaving cash available for debt reduction, shareholder returns, or further investment. The free-cash-flow margin was 43.1%, measuring cash remaining after capital spending against revenue. Measured against total assets, free cash flow represented 20.0%, showing the cash productivity of the company’s assets.
Based on the annual report for the fiscal year ending Dec 31, 2025. Analysis generated .
Sources and calculation details

Reported values are preserved. Derived values use the listed inputs; unavailable inputs remain blank.

Field-level sources for this historical record are unavailable until it is rebuilt from SEC facts.

Annual (FY)
Quarterly 🔒
Chart 🔒
Annual financial statements for COMPUGEN LTD
Metric FY2025 📄 FY2024 📄 FY2023 📄
Income Statement
REVENUE
Revenue $72.76M $27.86M $33.46M
Cost of Revenue $9.25M $7.93M $2.00M
Gross Profit $63.51M $19.93M $31.46M
OPERATING EXPENSES
R&D Expense $22.76M $24.81M $34.47M
SG&A Expense $8.89M $9.44M $9.73M
Other Operating Expenses (derived) $539.00K $576.00K $244.00K
Operating Income $31.33M $-14.89M $-12.99M
NON-OPERATING INCOME / EXPENSE
Interest Expense $28.00K $34.00K $31.00K
Interest Income $3.91M $3.49M $2.96M
Pretax Income $35.40M $-9.71M $-9.78M
Income Tax $54.00K $4.52M $8.97M
Net Income $35.34M $-14.23M $-18.75M
PER SHARE & SUPPLEMENTAL
Diluted EPS $0.38 $-0.16 $-0.21
Diluted Shares 93.82M 89.53M 87.63M
EBITDA $31.80M $-14.41M $-12.52M
Depreciation & Amortization $475.00K $486.00K $476.00K
Balance Sheet
ASSETS
Cash & Equivalents $90.60M $18.23M $13.89M
Short-term Investments $9.28M $23.63M $11.74M
Accounts Receivable - $0 $61.00M
Other Current Assets $144.00K $142.00K $226.00K
Current Assets $148.02M $106.00M $114.58M
PP&E (Net) $681.00K $852.00K $1.22M
Noncurrent Assets $8.55M $9.00M $6.76M
Total Assets $156.57M $115.00M $121.33M
LIABILITIES
Accounts Payable $2.35M $1.84M $3.50M
Other Current Liabilities - - $7.86M
Current Liabilities $22.57M $20.16M $26.27M
Other Noncurrent Liabilities $90.00K $58.00K $53.00K
Noncurrent Liabilities $31.27M $39.92M $29.51M
Total Liabilities $53.84M $60.08M $55.78M
EQUITY
Common Stock $262.00K $248.00K $247.00K
Additional Paid-in Capital $555.88M $543.41M $539.84M
Retained Earnings $-453.42M $-488.76M $-474.53M
Accumulated OCI $8.00K $11.00K $2.00K
Total Equity $102.73M $54.91M $65.56M
Total Liabilities & Equity $156.57M $115.00M $121.33M
SUPPLEMENTAL
Shares Outstanding 94.55M 89.54M 89.24M
Check: A − (L + E + NCI) - - -
Cash Flow Statement
Cash from Operations $31.63M $49.60M $-35.89M
Capital Expenditures $306.00K $118.00K $172.00K
Cash from Investing $30.00M $-46.25M $35.51M
Cash from Financing $10.60M $554.00K $3.08M
Free Cash Flow $31.33M $49.49M $-36.06M
Beginning Cash (CFS) $18.23M $14.26M -
Net Change in Cash $72.23M $3.91M -
Effect of FX on Cash $135.00K $68.00K $129.00K
Calculated Ending Cash $90.60M $18.23M -
Cash per BS $90.60M $18.23M $13.89M
Cash scope difference (CFS − BS) - - $365.00K
Cash per CFS $90.60M $18.23M $14.26M

Create a free account to see full history, quarterly data, charts, CSV downloads, and API access.

Create Free Account Log In
🔒

Quarterly data and charts require a free account

Get access to 8 quarters of data, interactive charts, CSV downloads, and API access.

▼ Frequently Asked Questions

What is COMPUGEN LTD's annual revenue?

COMPUGEN LTD reported $72.76M in revenue for fiscal year 2025 (ending December 2025). Revenue figures are sourced from the company's annual SEC EDGAR filing.

Is COMPUGEN LTD profitable?

Yes. COMPUGEN LTD reported $35.34M in net income for fiscal year 2025. Profitability data is based on the company's most recent annual report filed with the SEC.

Does COMPUGEN LTD generate free cash flow?

Yes. Free cash flow was $31.33M for fiscal year 2025. Operating cash flow was $31.63M.